Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Glenmark Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:532296NSE Symbol: GLENMARKP/E(TTM):28.26
ISIN Demat:INE935A01035Div & Yield %:0.24EPS(TTM):37.29
Book Value(Rs):651.2259081Market Cap ( Cr.):29742.63Face Value(Rs):1
    Change Company 
Date Headline
29-Apr-24 Glenmark receives USFDA approval for Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC)
29-Apr-24 Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Press Release
29-Apr-24 Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Press Release
29-Apr-24 Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Press Release
26-Apr-24 Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Credit Rating
15-Apr-24 Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Disclosure under SEBI Takeover Regulations
05-Apr-24 Glenmark Pharmaceuticals Ltd up for five straight sessions
01-Apr-24 Glenmark Pharmaceuticals directors resign
01-Apr-24 Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Change in Director
01-Apr-24 Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Retirement
<< < 1 2 3 4   > >>